CEO
Hikal Limited
Equibles does not estimate personal net worth.
Anish Swadi is recorded as CEO at Hikal Limited. Anish Swadi has spoken on 2 earnings calls across 1 company, most recently for Hikal Limited on November 3, 2026. Hikal Limited is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.
“This is continuing to grow in revenue this quarter. Our existing product portfolios will increase in volumes, and our new CDMO projects are progressing well.”
“First, I'd like to talk about our animal health business, where we continue to witness sustained momentum supported by increasing global outsourcing activity and improving customer engagement across the API CDMO segment.”
Hikal Limited
CEO
Transcript header (unverified)
Hikal Limited
Drug Manufacturers - Specialty & Generic · Healthcare
CEO
Earnings Call for the Quarter Ended September 30, 2026
Hikal Limited
Earnings Call for the Quarter Ended March 31, 2026
Hikal Limited
